DPP4 and cardiovascular disorder: Enhanced soluble DPP-IV levels and/or activity have been suggested to be a novel regulator of many metabolic diseases, such as type 2 diabetes (T2DM), obesity, cardiovascular disease, and non-alcoholic fatty liver disease [2,3].